Literature DB >> 15784868

Risk factors for relapse in health care professionals with substance use disorders.

Karen B Domino1, Thomas F Hornbein, Nayak L Polissar, Ginger Renner, Jilda Johnson, Scott Alberti, Lynn Hankes.   

Abstract

CONTEXT: Substance use disorders among physicians are important and persistent problems. Considerable debate exists over whether use of major opioids, especially among anesthesiologists, is associated with a higher relapse rate compared with alcohol and nonopioids. Moreover, the risk factors for relapse with current treatment and monitoring strategies are unknown.
OBJECTIVE: To test the hypothesis that chemically dependent health care professionals using a major opioid (eg, fentanyl, sufentanil, morphine, meperidine) as drug of choice are at higher risk of relapse. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 292 health care professionals enrolled in the Washington Physicians Health Program, an independent posttreatment monitoring program, followed up between January 1, 1991, and December 31, 2001. MAIN OUTCOME MEASURE: Factors associated with relapse, defined as the resumption of substance use after initial diagnosis and completion of primary treatment for chemical dependency.
RESULTS: Twenty-five percent (74 of 292 individuals) had at least 1 relapse. A family history of a substance use disorder increased the risk of relapse (hazard ratio [HR], 2.29; 95% confidence interval [CI], 1.44-3.64). The use of a major opioid increased the risk of relapse significantly in the presence of a coexisting psychiatric disorder (HR, 5.79; 95% CI, 2.89-11.42) but not in the absence of a coexisting psychiatric disorder (HR, 0.85; 95% CI, 0.33-2.17). The presence of all 3 factors--major opioid use, dual diagnosis, and family history--markedly increased the risk of relapse (HR, 13.25; 95% CI, 5.22-33.59). The risk of subsequent relapses increased after the first relapse (HR, 1.69; 95% CI, 1.13-2.53).
CONCLUSIONS: The risk of relapse with substance use was increased in health care professionals who used a major opioid or had a coexisting psychiatric illness or a family history of a substance use disorder. The presence of more than 1 of these risk factors and previous relapse further increased the likelihood of relapse. These observations should be considered in monitoring the recovery of health care professionals.

Entities:  

Mesh:

Year:  2005        PMID: 15784868     DOI: 10.1001/jama.293.12.1453

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  30 in total

Review 1.  Anesthesiology physician scientists in academic medicine: a wake-up call.

Authors:  Debra A Schwinn; Jeffrey R Balser
Journal:  Anesthesiology       Date:  2006-01       Impact factor: 7.892

2.  Using stories to disseminate research: the attributes of representative stories.

Authors:  John F Steiner
Journal:  J Gen Intern Med       Date:  2007-09-01       Impact factor: 5.128

Review 3.  Chemical dependency and the physician.

Authors:  Keith H Berge; Marvin D Seppala; Agnes M Schipper
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

4.  Anesthesiologists recovering from chemical dependency: can they safely return to the operating room?

Authors:  Michael R Oreskovich; Ryan M Caldeiro
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

5.  Confrontational approach has no role in addressing physician addiction.

Authors:  Gregory E Skipper
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 6.  Maintenance medication for opiate addiction: the foundation of recovery.

Authors:  Gavin Bart
Journal:  J Addict Dis       Date:  2012

7.  Determinants of fentanyl and other potent µ opioid agonist misuse in opioid-dependent individuals.

Authors:  Theodore J Cicero; Matthew S Ellis; Alethea Paradis; Zachary Ortbal
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-10       Impact factor: 2.890

8.  Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.

Authors:  Lisa J Merlo; William M Greene; Raymond Pomm
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

9.  Novel Objective Biomarkers of Alcohol Use: Potential Diagnostic and Treatment Management Tools in Dual Diagnosis Care.

Authors:  Raj K Kalapatapu; R Chambers
Journal:  J Dual Diagn       Date:  2009-01-01

10.  Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs).

Authors:  Michael L Dennis; Christy K Scott
Journal:  Drug Alcohol Depend       Date:  2011-09-07       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.